Top

Published in:

Open Access 01-11-2013 | Meeting abstract

P03-013 - Symptomatic neuromuscular sarcoidosis

Authors: M Mulazzani, C Haberler, F Zimprich, EV Hartl, H Cetin

Published in: Pediatric Rheumatology | Special Issue 1/2013

Excerpt

Sarcoidosis is a granulomatous disease possibly affecting all organ systems. Less than 10% of sarcoidosis patients develop symptomatic neurological involvement. Although muscular non-caseating granulomas (NCGs) can be found in up to 75% of sarcoidosis patients, muscular symptoms develop only in less than 0.5% of sarcoidosis patients. Corticosteroids (CS) are the mainstay of medical therapy, but their effect on chronic myopathy is not consistent. Additive immunosuppressive therapy with azathioprine, cyclophosphamide, methotrexate, or chloroquine may be necessary in patients inadequately responding to CSs. …

Zisman : Sarcoidosis involving the musculoskeletal system. Sem Resp Crit Care Med. 2002, 23: 555-70.CrossRef

Title: P03-013 - Symptomatic neuromuscular sarcoidosis
Authors: M Mulazzani
C Haberler
F Zimprich
EV Hartl
H Cetin
Publication date: 01-11-2013
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-11-S1-A210

At a glance: The STEP trials

Springer Medicine

P03-013 - Symptomatic neuromuscular sarcoidosis

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2013

PW03-024 - A transgenic mouse model for variant procaspase-1

P03-012 - A P268S NOD2 mutation in one Blau patient

P01-041 – Patient management and rare FMF symptoms

P01-049 – Assessment of vascular function in systemic JIA

PW01-031 – Treatment of FMF in middle and old age

PW03-002 – Calculating Gaslini diagnostic score in PFAPA